- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 6 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
UDP.2: 15 residues within 4Å:- Chain A: V.98, Y.107, F.109, Q.110, F.161, M.162, Y.165, N.166, W.170, R.185, V.186, Y.320, R.330, Y.422, Y.456
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:Y.107, A:F.161
- Hydrogen bonds: A:F.109, A:Q.110, A:Q.110, A:N.166, A:N.166, A:Y.320, A:Y.320, A:Y.456, A:Y.456
- Salt bridges: A:R.185, A:R.330, A:R.330
- pi-Stacking: A:Y.320
UDP.9: 6 residues within 4Å:- Chain A: K.291, L.293, F.294, Y.295, S.380, S.381
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.293, A:Y.295, A:Y.295, A:S.381
UDP.13: 18 residues within 4Å:- Chain B: V.98, Y.107, P.108, F.109, Q.110, F.145, F.161, M.162, Y.165, N.166, W.170, R.185, V.186, Y.320, R.330, Y.422, Y.456
- Ligands: EDO.23
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:Y.107, B:F.161
- Hydrogen bonds: B:F.109, B:Q.110, B:Q.110, B:N.166, B:N.166, B:R.185, B:Y.320, B:Y.422, B:Y.456, B:Y.456
- Water bridges: B:A.187, B:A.187
- Salt bridges: B:R.330, B:R.330
- pi-Stacking: B:Y.320
UDP.20: 6 residues within 4Å:- Chain B: K.291, L.293, F.294, Y.295, S.380, S.381
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:L.293, B:Y.295, B:Y.295, B:S.381
- Salt bridges: B:K.291
- pi-Stacking: B:F.294
UDP.32: 6 residues within 4Å:- Chain C: K.291, L.293, F.294, Y.295, S.380, S.381
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:L.293, C:Y.295, C:Y.295, C:S.381
UDP.44: 6 residues within 4Å:- Chain D: K.291, L.293, F.294, Y.295, S.380, S.381
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:L.293, D:Y.295, D:Y.295, D:S.381
- 26 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: V.150, T.155, R.163
Ligand excluded by PLIPSO4.6: 2 residues within 4Å:- Chain A: K.73, R.499
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: R.309, D.315
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: N.43, D.53, R.416
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: R.309, D.315
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain B: K.73, R.499
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain B: N.43, D.53, R.416
Ligand excluded by PLIPSO4.19: 2 residues within 4Å:- Chain B: K.85, E.86
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain C: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain C: V.150, T.155, R.163
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain C: P.117, K.118
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain C: R.309, D.315
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain C: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain C: K.73, R.499
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain C: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.37: 4 residues within 4Å:- Chain D: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain D: P.117, K.118
Ligand excluded by PLIPSO4.39: 5 residues within 4Å:- Chain D: R.94, S.96, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain D: R.309, D.315
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain D: N.43, D.53, R.416
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain D: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.43: 2 residues within 4Å:- Chain D: T.155, R.163
Ligand excluded by PLIP- 11 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 3 residues within 4Å:- Chain A: W.446, N.474
- Chain C: E.497
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:N.474
- Water bridges: C:T.496
EDO.11: 4 residues within 4Å:- Chain A: R.306, G.307, D.408, E.409
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.408, A:E.409
EDO.21: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.22: 3 residues within 4Å:- Chain B: W.446, N.474
- Chain D: E.497
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain B- Water bridges: D:T.496
- Hydrogen bonds: B:N.474, B:N.474
EDO.23: 6 residues within 4Å:- Chain B: G.65, V.67, W.318, R.330
- Ligands: FDA.12, UDP.13
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.330
EDO.33: 3 residues within 4Å:- Chain A: E.497
- Chain C: W.446, N.474
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain C- Water bridges: A:T.496
- Hydrogen bonds: C:N.474, C:N.474
EDO.34: 6 residues within 4Å:- Chain C: V.67, I.68, F.69, R.94, N.460
- Ligands: FDA.24
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.94, C:R.94
EDO.35: 4 residues within 4Å:- Chain C: R.306, G.307, D.408, E.409
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:D.408, C:E.409
EDO.45: 3 residues within 4Å:- Chain B: E.497
- Chain D: W.446, N.474
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain D- Water bridges: B:T.496
- Hydrogen bonds: D:N.474, D:N.474
EDO.46: 5 residues within 4Å:- Chain D: G.65, V.67, W.318, R.330
- Ligands: FDA.36
2 PLIP interactions:2 interactions with chain D- Water bridges: D:R.330, D:T.332
EDO.47: 8 residues within 4Å:- Chain D: Q.110, M.128, M.152, M.153, A.188, P.189, N.190, V.194
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.110, D:N.190
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 6 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
- 26 x SO4: SULFATE ION(Non-functional Binders)
- 11 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D